In a filing, Biomarin Pharmaceutical Inc revealed its GVP, Chief Accounting Officer Burkhart Erin unloaded Company’s shares for reported $0.11 million on May 20 ’25. In the deal valued at $59.31 per share,1,786 shares were sold. As a result of this transaction, Burkhart Erin now holds 14,173 shares worth roughly $0.8 million.
Then, Burkhart Erin bought 1,786 shares, generating $105,928 in total proceeds.
Before that, Hubbard Cristin sold 273 shares. Biomarin Pharmaceutical Inc shares valued at $17,723 were divested by the EVP, Chief Commercial Officer at a price of $64.92 per share. As a result of the transaction, Hubbard Cristin now holds 32,700 shares, worth roughly $1.85 million.
A number of analysts have revised their coverage, including Oppenheimer’s analysts, who increased its forecast for the stock in late February from “a Perform” to “an Outperform”. Wolfe Research began covering BMRN with “an Outperform” recommendation on November 15, 2024. William Blair revised its rating on October 30, 2024. It rated BMRN as “a Mkt perform” which previously was an “an Outperform”.
Price Performance Review of BMRN
On Tuesday, Biomarin Pharmaceutical Inc [NASDAQ:BMRN] saw its stock fall -2.76% to $56.62. Over the last five days, the stock has lost -2.36%. Biomarin Pharmaceutical Inc shares have fallen nearly -32.52% since the year began. Nevertheless, the stocks have fallen -13.86% over the past one year. While a 52-week high of $94.85 was reached on 03/07/25, a 52-week low of $52.93 was recorded on 04/09/25.
Levels Of Support And Resistance For BMRN Stock
The 24-hour chart illustrates a support level at 55.87, which if violated will result in even more drops to 55.12. On the upside, there is a resistance level at 58.02. A further resistance level may holdings at 59.41.
How much short interest is there in Biomarin Pharmaceutical Inc?
A steep rise in short interest was recorded in Biomarin Pharmaceutical Inc stocks on 2025-06-13, dropping by 32450.0 shares to a total of 4.42 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 4.45 million shares. There was a decline of -0.73%, which implies that there is a negative sentiment for the stock.
